RightShip is pleased to welcome Next Link to the Zero Harm Innovation Partners Program, strengthening our shared commitment to improving safety by addressing human-related risks in maritime operations. Next Link delivers a simple, low-burden substance screening solution designed to support safer working environments at sea. By enabling accurate detection of multiple substances through a non-invasive gauze-based method, combined with secure laboratory analysis and cloud-based reporting, their approach supports early identification of risks that may impact crew wellbeing and operational safety. This partnership reflects the industry’s growing focus on proactively managing human factors as a critical component of the Zero Harm vision. Addressing Human Risk in Maritime Operations Next Link joined the Zero Harm Innovation Partners Program with the objective of helping mitigate human error by addressing substance-related risks in the shipping industry. Substance misuse remains a recognised safety concern, with the potential to impact decision-making, performance, and overall vessel safety. By participating in the program, Next Link contributes to a broader network of organisations focused on reducing risk and strengthening safety culture across maritime operations. This collaboration supports greater awareness of human-related risks and encourages the adoption of preventative measures that promote safer, healthier crews. A Practical Approach to Screening at Sea Traditional testing methods can present logistical and psychological barriers, particularly in maritime environments where accessibility and efficiency are critical. Next Link’s solution addresses these challenges through a streamlined and minimally invasive process. Samples are collected through a simple gauze wipe, sent for laboratory analysis, and results are delivered via a secure cloud platform within a short timeframe. This approach reduces disruption to operations while maintaining accuracy and reliability.